<codeBook xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xsi:schemaLocation="ddi:codebook:2_6 http://www.ddialliance.org/Specification/DDI-Codebook/2.6/XMLSchema/codebook.xsd" xmlns="ddi:codebook:2_6">
  <docDscr>
    <citation>
      <titlStmt>
        <titl xml:lang="sv">Data for: Identifiering av proteinbiomarkörer för att skilja mellan gram-negativ och gram-positiv infektioner hos vuxna patienter</titl>
        <parTitl xml:lang="en">Data for: Identification of protein biomarkers to differentiate between gram-negative and gram-positive infections in adult patients</parTitl>
        <IDNo agency="SND">2024-65-1</IDNo>
        <IDNo agency="DOI">https://doi.org/10.5878/5tfb-b833</IDNo>
      </titlStmt>
      <prodStmt>
        <producer xml:lang="en" abbr="SND">Swedish National Data Service</producer>
        <producer xml:lang="sv" abbr="SND">Svensk nationell datatjänst</producer>
      </prodStmt>
      <holdings URI="https://doi.org/10.5878/5tfb-b833">Landing page</holdings>
    </citation>
  </docDscr>
  <stdyDscr>
    <citation>
      <titlStmt>
        <titl xml:lang="sv">Data for: Identifiering av proteinbiomarkörer för att skilja mellan gram-negativ och gram-positiv infektioner hos vuxna patienter</titl>
        <parTitl xml:lang="en">Data for: Identification of protein biomarkers to differentiate between gram-negative and gram-positive infections in adult patients</parTitl>
        <IDNo agency="SND">2024-65-1</IDNo>
        <IDNo agency="DOI">https://doi.org/10.5878/5tfb-b833</IDNo>
      </titlStmt>
      <rspStmt>
        <AuthEnty xml:lang="en" affiliation="University of Gothenburg">Irani Shemirani, Mahnaz</AuthEnty>
        <AuthEnty xml:lang="sv" affiliation="Göteborgs universitet">Irani Shemirani, Mahnaz</AuthEnty>
        <AuthEnty xml:lang="en" affiliation="School of Bioscience, University of Skövde">Tilevik, Diana</AuthEnty>
        <AuthEnty xml:lang="sv" affiliation="Institutionen för biovetenskap, Högskolan i Skövde">Tilevik, Diana</AuthEnty>
      </rspStmt>
      <prodStmt />
      <distStmt>
        <distrbtr xml:lang="en" abbr="SND" URI="https://snd.se">Swedish National Data Service</distrbtr>
        <distrbtr xml:lang="sv" abbr="SND" URI="https://snd.se">Svensk nationell datatjänst</distrbtr>
        <distDate xml:lang="en" date="2026-11-16" />
      </distStmt>
      <verStmt>
        <version elementVersion="1" elementVersionDate="2026-11-16" />
      </verStmt>
      <holdings URI="https://doi.org/10.5878/5tfb-b833">Landing page</holdings>
    </citation>
    <stdyInfo>
      <subject>
        <keyword xml:lang="en" vocab="YSO" vocabURI="http://www.yso.fi/onto/yso/p21846">machine learning</keyword>
        <keyword xml:lang="sv" vocab="YSO" vocabURI="http://www.yso.fi/onto/yso/p21846">maskininlärning</keyword>
        <keyword xml:lang="en" vocab="YSO" vocabURI="http://www.yso.fi/onto/yso/p7548">proteomics</keyword>
        <keyword xml:lang="sv" vocab="YSO" vocabURI="http://www.yso.fi/onto/yso/p7548">proteomik</keyword>
        <keyword xml:lang="en" vocab="YSO" vocabURI="http://www.yso.fi/onto/yso/p8762">sepsis</keyword>
        <keyword xml:lang="sv" vocab="YSO" vocabURI="http://www.yso.fi/onto/yso/p8762">blodförgiftning</keyword>
      </subject>
      <abstract xml:lang="en" contentType="abstract">Protein quantification conducted using Protein Extension Assay (PEA) at TATAA Biocenter, Gothenburg, Sweden following the manufacturer’s instructions. Four Olink biomarker panels— Cardiometabolic (v.3603), Cardiovascular II (v.5004), Immune Response (v.3202), and Inflammation (v.3021)— were employed to analyze proteins in the blood samples collected from 291 patients diagnosed with bacterial sepsis, including 184 with gram-negative and 107 with gram-positive bacterial sepsis, along with 40 healthy control individuals.</abstract>
      <abstract xml:lang="sv" contentType="abstract">Proteinkvantifiering utförd med Protein Extension Assay (PEA) vid TATAA Biocenter, Göteborg, Sverige enligt tillverkarens instruktioner. Fyra Olink-biomarkörpaneler – Cardiometabolic (v.3603), Cardiovascular II (v.5004), Immune Response (v.3202) och Inflammation (v.3021) – användes för att analysera proteiner i blodproverna från 291 diagnostiserade patienter med bakteriell sepsis, inklusive 184 med gram-negativ och 107 med gram-positiv bakteriell sepsis, tillsammans med 40 friska kontrollindivider.
​</abstract>
      <sumDscr>
        <nation xml:lang="en" abbr="SE">Sweden</nation>
        <nation xml:lang="sv" abbr="SE">Sverige</nation>
        <universe xml:lang="en">Data and samples originated from a prospective observational study of community-onset severe sepsis and septic shock in adults conducted at Skaraborg Hospital, Sweden. The study was approved by the Regional Ethical Review Board of Gothenburg (376-11) and only included participants who gave their written informed consent. 
The sampling for laboratory data was performed at the time of admission to the emergency department according to routine hospital procedures and prior to the administration of antibiotic therapy. To identify species type, microbiological culturing was performed as previously described. All medical records were retrospectively reviewed by two senior specialists in infectious diseases to determine whether the patients fulfilled Sepsis-3 criteria. Following the review, it was found that not all patients met the criteria for sepsis. According to Sepsis-3 criteria, bacterial sepsis was defined as bacterial infection-induced organ dysfunction characterized by a rise in total SOFA ≥2. Verified bacterial infection was defined as a clinical infection with identification of relevant bacteria by culture or typical clinical symptoms, such as erysipelas. The patients included in the current study were those with a verified bacterial infection. For protein quantification, blood samples were collected using sodium citrate tubes, and plasma was stored at -80 °C until subsequent analysis.  The blood samples were collected from 291 patients diagnosed with bacterial sepsis, including 184 with gram-negative and 107 with gram-positive bacterial sepsis, along with 40 healthy control individuals.</universe>
        <universe xml:lang="sv">Data och prover härrörde från en prospektiv observationsstudie av allvarlig sepsis och septisk chock hos vuxna utförd på Skaraborgs sjukhus, Sverige. Studien godkändes av Regionala etikprövningsnämnden i Göteborg (376-11) och omfattade endast deltagare som lämnat sitt skriftliga informerade samtycke.
Provtagningen för laboratoriedata utfördes vid inläggningen på akutmottagningen enligt rutinmässiga sjukhusprocedurer och före administrering av antibiotikabehandling. För att identifiera arttyp utfördes mikrobiologisk odling som tidigare beskrivits. Alla journaler granskades i efterhand av två seniora specialister på infektionssjukdomar för att avgöra om patienterna uppfyllde Sepsis-3-kriterierna. Enligt Sepsis-3 kriterier definierades bakteriell sepsis som bakteriell infektionsinducerad organdysfunktion kännetecknad av en ökning av total SOFA ≥2, medan verifierad bakterieinfektion definierades som en klinisk infektion och identifiering av relevanta bakterier genom odling, eller som typisk klinisk symtom, såsom erysipelas. För proteinkvantifiering togs blodprover med användning av natriumcitratrör och plasma lagrades vid -80 °C tills efterföljande analys. Blodproverna samlades in från 291 patienter diagnostiserade med bakteriell sepsis, inklusive 184 med gramnegativ och 107 med grampositiv bakteriell sepsis, tillsammans med 40 friska kontrollindivider.</universe>
        <dataKind xml:lang="en">Numeric</dataKind>
        <dataKind xml:lang="en">Text</dataKind>
        <dataKind xml:lang="en">Other</dataKind>
      </sumDscr>
    </stdyInfo>
    <method>
      <dataColl />
    </method>
    <dataAccs>
      <useStmt>
        <restrctn xml:lang="en">Access to data through SND. Access to data is restricted.</restrctn>
        <restrctn xml:lang="sv">Åtkomst till data via SND. Tillgång till data är begränsad.</restrctn>
        <conditions elementVersion="info:eu-repo-Access-Terms vocabulary">restrictedAccess</conditions>
      </useStmt>
    </dataAccs>
    <othrStdyMat>
      <relPubl>
        <citation>
          <titlStmt>
            <titl xml:lang="sv">Shemirani, M. I.,Pernestig, A.-K., Björkman, J., Tilevik, D., von Mentzer, A., Ejdebäck, M.,  Ståhlberg, A. (2024). Identification of protein biomarkers to differentiate between gram-negative and gram-positive infections in adult patients, BMC Infectious Disease [Under Review]</titl>
            <parTitl xml:lang="en">Shemirani, M. I.,Pernestig, A.-K., Björkman, J., Tilevik, D., von Mentzer, A., Ejdebäck, M.,  Ståhlberg, A. (2024). Identification of protein biomarkers to differentiate between gram-negative and gram-positive infections in adult patients, BMC Infectious Disease [Under Review]</parTitl>
          </titlStmt>
          <distStmt />
        </citation>
      </relPubl>
    </othrStdyMat>
  </stdyDscr>
</codeBook>